This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board meeting for financial results postponed to November 4, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.8 pts more than Nifty Microcap 250 and 4.6 pts more than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board meeting scheduled for October 30, 2026 has been postponed to November 4, 2026 due to unavoidable circumstances. The trading window has been closed since October 1 and will remain closed until 48 hours after the meeting concludes.
The results announcement is delayed, while the extended trading restriction limits insider trading. No details on financial performance are provided.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹7.11 Cr | ₹12.09 Cr | −41.2% |
| Operating profit | ₹0.74 Cr | ₹0.90 Cr | −18.2% |
| Profit after tax | ₹0.92 Cr | ₹0.71 Cr | +30.1% |
| EBITDA margin | 11.8% | 8.4% | +3.4 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.